Dr. Mostaghimi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
221 Longwood Ave
Boston, MA 02115Phone+1 617-732-5889Fax+1 617-582-6060
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Internal Medicine/Dermatology, 2007 - 2012
- Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2008 - 2008
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2007 - 2008
- Harvard Medical SchoolClass of 2007
Certifications & Licensure
- NH State Medical License 2022 - 2026
- MA State Medical License 2012 - 2024
- American Board of Dermatology Dermatology
- American Board of Internal Medicine Internal Medicine
- American Board of Preventive Medicine Clinical Informatics
Publications & Presentations
PubMed
- 3 citationsPost-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus.S Ingen-Housz-Oro, V Schmidt, M M Ameri, R Abe, A Brassard
Orphanet Journal of Rare Diseases. 2023-02-22 - 24 citationsSociety of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.Lucia Seminario-Vidal, Daniela Kroshinsky, Stephen J. Malachowski, James Sun, Alina Markova
Journal of the American Academy of Dermatology. 2020-06-01 - 54 citationsDevelopment and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10Megan H. Noe, Misha Rosenbach, Rebecca A. Hubbard, Arash Mostaghimi, Adela R. Cardones
JAMA Dermatology. 2019-04-01
Journal Articles
- Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne with SpironolactoneJohn S Barbieri, David J Margolis, Arash Mostaghimi, JAMA Dermatology
- Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the USArash Mostaghimi, MD, JAMA Dermatology
- Assessment of Sales and Marketing of Online Vouchers for Discounted Direct-to-Consumer Medical Imaging ServicesMegan Noe, Arash Mostaghimi, JAMA Internal Medicine
- Join now to see all
Authored Content
- Alopecia Linked to Autoimmune & Psychiatric ComorbiditiesSeptember 2024
- CellulitisSeptember 2020
Press Mentions
- Sun Pharma Presents New Clinical Efficacy, Safety Data in Severe Dermatological Conditions at 2024 EADV CongressSeptember 26th, 2024
- Alopecia Linked to Autoimmune & Psychiatric ComorbiditiesSeptember 3rd, 2024
- Do You Have Patients with JAKne — JAK Inhibitor–Associated Acne? Here’s What to KnowAugust 22nd, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: